Patient safety is our highest priority. The Global Patient Safety department serves patients by monitoring the safety of Amgen products (medicine, devices and combination products) through the science of Pharmacovigilance. Pharmacovigilance refers to the monitoring, reviewing, evaluating and communicating of information on the safety of pharmaceutical products.
Global Patient Safety takes a comprehensive and rigorous approach to pharmacovigilance activities. We are dedicated to establishing, maintaining, and communicating quality safety information throughout the life-cycle of Amgen products. Since patient safety is so critical, it is important that we share our approach to pharmacovigilance and our commitment to patient safety.
Part of Amgen's mission to serve patients includes collecting, reviewing and reporting all Adverse Event or Adverse Experience (AE) information associated with the use of Amgen's investigational or marketed products.